<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Stensland ZC</submitter><funding>Network for Pancreatic Organ Donors</funding><funding>Leona M. and Harry B. Helmsley Charitable Trust</funding><funding>NIDDK NIH HHS</funding><funding>National Institutes of Health</funding><funding>JDRF</funding><funding>NIH HHS</funding><pagination>e20221604</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10192302</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>220(8)</volume><pubmed_abstract>Recent evidence suggests a role for B cells in the pathogenesis of young-onset type 1 diabetes (T1D), wherein rapid progression occurs. However, little is known regarding the specificity, phenotype, and function of B cells in young-onset T1D. We performed a cross-sectional analysis comparing insulin-reactive to tetanus-reactive B cells in the blood of T1D and controls using mass cytometry. Unsupervised clustering revealed the existence of a highly activated B cell subset we term BND2 that falls within the previously defined anergic BND subset. We found a specific increase in the frequency of insulin-reactive BND2 cells in the blood of young-onset T1D donors, which was further enriched in the pancreatic lymph nodes of T1D donors. The frequency of insulin-binding BND2 cells correlated with a</pubmed_abstract><journal>The Journal of experimental medicine</journal><pubmed_title>Identification of an anergic BND cell-derived activated B cell population (BND2) in young-onset type 1 diabetes patients.</pubmed_title><pmcid>PMC10192302</pmcid><funding_grant_id>P30DK116073</funding_grant_id><funding_grant_id>K01OD028759</funding_grant_id><funding_grant_id>P30 DK116073</funding_grant_id><funding_grant_id>R03 DK129925</funding_grant_id><funding_grant_id>R03DK129925</funding_grant_id><funding_grant_id>R03 OD036470</funding_grant_id><funding_grant_id>G-2108-04793</funding_grant_id><funding_grant_id>2018PG-T1D053</funding_grant_id><funding_grant_id>K01 OD028759</funding_grant_id><pubmed_authors>Stensland ZC</pubmed_authors><pubmed_authors>Wells KL</pubmed_authors><pubmed_authors>Smith MJ</pubmed_authors><pubmed_authors>Rihanek M</pubmed_authors><pubmed_authors>Rios-Guzman NM</pubmed_authors><pubmed_authors>Gottlieb PA</pubmed_authors><pubmed_authors>Gomez BD</pubmed_authors><pubmed_authors>Nicholas CA</pubmed_authors><pubmed_authors>Hunter MJ</pubmed_authors><pubmed_authors>Magera CA</pubmed_authors><pubmed_authors>Toole KP</pubmed_authors><pubmed_authors>Broncucia H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Identification of an anergic BND cell-derived activated B cell population (BND2) in young-onset type 1 diabetes patients.</name><description>Recent evidence suggests a role for B cells in the pathogenesis of young-onset type 1 diabetes (T1D), wherein rapid progression occurs. However, little is known regarding the specificity, phenotype, and function of B cells in young-onset T1D. We performed a cross-sectional analysis comparing insulin-reactive to tetanus-reactive B cells in the blood of T1D and controls using mass cytometry. Unsupervised clustering revealed the existence of a highly activated B cell subset we term BND2 that falls within the previously defined anergic BND subset. We found a specific increase in the frequency of insulin-reactive BND2 cells in the blood of young-onset T1D donors, which was further enriched in the pancreatic lymph nodes of T1D donors. The frequency of insulin-binding BND2 cells correlated with a</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Aug</publication><modification>2026-04-29T02:24:05.795Z</modification><creation>2024-11-07T02:43:21.178Z</creation></dates><accession>S-EPMC10192302</accession><cross_references><pubmed>37184563</pubmed><doi>10.1084/jem.20221604</doi></cross_references></HashMap>